Drug ApprovalsFDA clears first DNA immunotherapy for rare airway disease RRP
Voceryq won accelerated approval after a trial of 32 adults in which about a quarter needed no surgery for their papillomas in the following year.
30 October 2026
Clinical trials, drug development and research news
Tag
Drug ApprovalsVoceryq won accelerated approval after a trial of 32 adults in which about a quarter needed no surgery for their papillomas in the following year.
30 October 2026
Drug ApprovalsJemperli won accelerated approval for dMMR or MSI-H stage II and III rectal cancer after most AZUR-1 patients needed no chemotherapy, radiotherapy or surgery.
19 October 2026
Approved does not always mean available. This guide explains how the FDA, MHRA and EMA review medicines, how NICE decides NHS funding, and why countries differ.
8 October 2026